Molecular Structure, Binding Affinity, and Biological Activity in the Epigenome
暂无分享,去创建一个
[1] A. Kukol,et al. Molecular Modeling of Proteins , 2008, Methods Molecular Biology™.
[2] Åsa K. Björklund,et al. A comprehensive map coupling histone modifications with gene regulation in adult dopaminergic and serotonergic neurons , 2018, Nature Communications.
[3] Haitao Li,et al. Systematic Profiling of Histone Readers in Arabidopsis thaliana. , 2018, Cell reports.
[4] F. Ji,et al. Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines. , 2017, International journal of oncology.
[5] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[6] István Horváth,et al. Mobility-based prediction of hydration structures of protein surfaces , 2015, Bioinform..
[7] A. Tarakhovsky,et al. Epigenetic drug discovery: breaking through the immune barrier , 2016, Nature Reviews Drug Discovery.
[8] Robin Holliday,et al. Epigenetics: A Historical Overview , 2006, Epigenetics.
[9] B. Porse,et al. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas , 2017, Nature Medicine.
[10] Ora Schueler-Furman,et al. Protein-peptide docking: opportunities and challenges. , 2018, Drug discovery today.
[11] L. Kavraki,et al. Understanding the challenges of protein flexibility in drug design , 2015, Expert opinion on drug discovery.
[12] Chun-yang Zhang,et al. Recent advances in histone modification and histone modifying enzyme assays , 2019, Expert review of molecular diagnostics.
[13] C. Glass,et al. The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.
[14] Jian-hui Jiang,et al. Peptide-templated gold nanocluster beacon as a sensitive, label-free sensor for protein post-translational modification enzymes. , 2013, Analytical chemistry.
[15] T. Eggermann,et al. Genomic imprinting disorders: lessons on how genome, epigenome and environment interact , 2019, Nature Reviews Genetics.
[16] Michelle D. Wang,et al. Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes. , 2005, Journal of molecular biology.
[17] U Stocker,et al. Molecular dynamics simulation of hen egg white lysozyme: A test of the GROMOS96 force field against nuclear magnetic resonance data , 2000, Proteins.
[18] Harren Jhoti,et al. High-throughput crystallography for lead discovery in drug design , 2002, Nature Reviews Drug Discovery.
[19] D. Patel,et al. ATRX ADD domain links an atypical histone methylation recognition mechanism to human mental-retardation syndrome. , 2011, Nature structural & molecular biology.
[20] C. Atilgan,et al. In silico mutational studies of Hsp70 disclose sites with distinct functional attributes , 2015, Proteins.
[21] S. Choubey,et al. Molecular dynamics and quantum chemistry-based approaches to identify isoform selective HDAC2 inhibitor – a novel target to prevent Alzheimer’s disease , 2018, Journal of receptor and signal transduction research.
[22] P. Grant,et al. Effector Proteins for Methylated Histones: An Expanding Family , 2005, Cell cycle.
[23] Qingchuan Zheng,et al. A molecular dynamics investigation into the mechanisms of alectinib resistance of three ALK mutants , 2018, Journal of cellular biochemistry.
[24] Jessica A. Engel,et al. Design and Synthesis of Novel Anti‐Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit , 2017, Archiv der Pharmazie.
[25] N. Dokholyan,et al. Limits in accuracy and a strategy of RNA structure prediction using experimental information , 2019, Nucleic acids research.
[26] Hanoch Senderowitz,et al. Toward Focusing Conformational Ensembles on Bioactive Conformations: A Molecular Mechanics/Quantum Mechanics Study , 2015, J. Chem. Inf. Model..
[27] M. Dawson,et al. Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.
[28] A. Rescifina,et al. The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat , 2017, Medicinal research reviews.
[29] A. Shilatifard,et al. Covalent modifications of histones during development and disease pathogenesis , 2007, Nature Structural &Molecular Biology.
[30] Zissimos Mourelatos,et al. The microRNA world: small is mighty. , 2003, Trends in biochemical sciences.
[31] Garland R. Marshall,et al. An Automated Strategy for Binding-Pose Selection and Docking Assessment in Structure-Based Drug Design , 2016, J. Chem. Inf. Model..
[32] D. Patel,et al. TRIM24 links a noncanonical histone signature to breast cancer , 2010, Nature.
[33] W. Sippl,et al. Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors. , 2015, Journal of molecular graphics & modelling.
[34] Vladimir B. Sulimov,et al. Mixed implicit/explicit solvation models in quantum mechanical calculations of binding enthalpy for protein–ligand complexes , 2006 .
[35] Kurt Wüthrich,et al. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures , 2018, Nature Reviews Drug Discovery.
[36] H. Bjornsson. The Mendelian disorders of the epigenetic machinery , 2015, Genome research.
[37] M. Sweet,et al. Histone deacetylases as regulators of inflammation and immunity. , 2011, Trends in immunology.
[38] Manel Esteller,et al. Clinical epigenetics: seizing opportunities for translation , 2018, Nature Reviews Genetics.
[39] Didier Devaurs,et al. DINC 2.0: A New Protein-Peptide Docking Webserver Using an Incremental Approach. , 2017, Cancer research.
[40] S. Choubey,et al. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study. , 2016, Journal of molecular graphics & modelling.
[41] Quantitative chromatin proteomics reveals a dynamic histone post-translational modification landscape that defines asexual and sexual Plasmodium falciparum parasites , 2017, Scientific Reports.
[42] D. Patel,et al. Readout of epigenetic modifications. , 2013, Annual review of biochemistry.
[43] A. García-Sáez,et al. Quantitative interactome of a membrane Bcl-2 network identifies a hierarchy of complexes for apoptosis regulation , 2017, Nature Communications.
[44] M. Poirier,et al. Single molecule fluorescence methodologies for investigating transcription factor binding kinetics to nucleosomes and DNA. , 2014, Methods.
[45] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[46] J. Fraser,et al. Integrative, dynamic structural biology at atomic resolution—it's about time , 2015, Nature Methods.
[47] B. Fierz,et al. A two-state activation mechanism controls the histone methyltransferase Suv39h1 , 2016, Nature chemical biology.
[48] Ora Schueler-Furman,et al. Rosetta FlexPepDock web server—high resolution modeling of peptide–protein interactions , 2011, Nucleic Acids Res..
[49] R. Kornberg,et al. Twenty-Five Years of the Nucleosome, Fundamental Particle of the Eukaryote Chromosome , 1999, Cell.
[50] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[51] R. Konrat,et al. A histone-mimicking interdomain linker in a multidomain protein modulates multivalent histone binding , 2017, The Journal of Biological Chemistry.
[52] S. Counce. The Strategy of the Genes , 1958, The Yale Journal of Biology and Medicine.
[53] H. Dyson,et al. Intrinsically disordered proteins in cellular signalling and regulation , 2014, Nature Reviews Molecular Cell Biology.
[54] B. Jayashree,et al. Novel flavonol analogues as potential inhibitors of JMJD3 histone demethylase-A study based on molecular modelling. , 2017, Journal of molecular graphics & modelling.
[55] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[56] A. Salleo,et al. 0 O ct 2 01 3 Multi-phase semicrystalline microstructures drive exciton dissociation in neat plastic semiconductors , 2013 .
[57] Xianglin Shi,et al. Upregulation of histone‐lysine methyltransferases plays a causal role in hexavalent chromium‐induced cancer stem cell‐like property and cell transformation , 2018, Toxicology and applied pharmacology.
[58] R. Henderson,et al. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.
[59] C. Allis,et al. Epigenetics: A Landscape Takes Shape , 2007, Cell.
[60] T. Lappalainen,et al. Associating cellular epigenetic models with human phenotypes , 2017, Nature Reviews Genetics.
[61] Osamu Miyashita,et al. Role of Computational Methods in Going beyond X-ray Crystallography to Explore Protein Structure and Dynamics , 2018, International journal of molecular sciences.
[62] R. Dingledine,et al. A Set of Time-Resolved Fluorescence Resonance Energy Transfer Assays for the Discovery of Inhibitors of Estrogen Receptor-Coactivator Binding , 2009, Journal of biomolecular screening.
[63] Evert Bosdriesz,et al. An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential , 2018, Cell.
[64] R. Boelens,et al. DNA repair factor APLF acts as a H2A-H2B histone chaperone through binding its DNA interaction surface , 2018, Nucleic acids research.
[65] J. W. Picking,et al. Histone H3 phosphorylation near the nucleosome dyad alters chromatin structure , 2014, Nucleic acids research.
[66] K. Luger,et al. Nucleosome structure and dynamics are coming of age , 2018, Nature Structural & Molecular Biology.
[67] N. Sharma,et al. Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer , 2019, The Protein Journal.
[68] F. Ji,et al. An inhibitor of the acetyltransferases CBP/p300 exerts antineoplastic effects on gastrointestinal stromal tumor cells. , 2016, Oncology reports.
[69] C. Bountra,et al. Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.
[70] D. R. Gruber,et al. Oxidative damage to epigenetically methylated sites affects DNA stability, dynamics and enzymatic demethylation , 2018, Nucleic acids research.
[71] Zhiguo Zhang,et al. Histone H3-K56 acetylation is important for genomic stability in mammals , 2009, Cell cycle.
[72] Edison T. Liu,et al. Regulation of Transcription through Acetylation of H3K122 on the Lateral Surface of the Histone Octamer , 2013, Cell.
[73] Yuan Yuan,et al. Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach , 2018, Journal of biomolecular structure & dynamics.
[74] Cheng Luo,et al. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays. , 2017, Bioorganic & medicinal chemistry letters.
[75] Takayoshi Suzuki,et al. Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure-activity relationship analysis. , 2016, Bioorganic & medicinal chemistry letters.
[76] Enguo Fan,et al. Analytical strategies used to identify the readers of histone modifications: A review. , 2015, Analytica chimica acta.
[77] M. Esteller,et al. Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.
[78] T. Richmond,et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.
[79] Yun Song,et al. Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors , 2018, Nature Communications.
[80] S. Beck,et al. From profiles to function in epigenomics , 2016, Nature Reviews Genetics.
[81] W. Bragg,et al. The Structure of the Diamond , 1913, Nature.
[82] David T. Brown,et al. Molecular dynamics of histone H1. , 2016, Biochimica et biophysica acta.
[83] P. Varadwaj,et al. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors , 2017, Journal of biomolecular structure & dynamics.
[84] D. Ansari,et al. In vitro cytotoxicity evaluation of HDAC inhibitor Apicidin in pancreatic carcinoma cells subsequent time and dose dependent treatment. , 2015, Toxicology letters.
[85] R. Stote,et al. Molecular dynamics for computational proteomics of methylated histone H3. , 2015, Biochimica et biophysica acta.
[86] Martin Zacharias,et al. iATTRACT: Simultaneous global and local interface optimization for protein–protein docking refinement , 2015, Proteins: Structure, Function, and Bioinformatics.
[87] L. Fritsch,et al. Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a , 2007, Genome Biology.
[88] D. Patel,et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF , 2006, Nature.
[89] B. Simon,et al. NMR Structure of the First PHD Finger of Autoimmune Regulator Protein (AIRE1) , 2005, Journal of Biological Chemistry.
[90] Zhiqiang Cheng,et al. Kinetic and high-throughput profiling of epigenetic interactions by 3D-carbene chip-based surface plasmon resonance imaging technology , 2017, Proceedings of the National Academy of Sciences.
[91] R. Russell,et al. Structural systems biology: modelling protein interactions , 2006, Nature Reviews Molecular Cell Biology.
[92] M. Amanlou,et al. A comparative study based on docking and molecular dynamics simulations over HDAC-tubulin dual inhibitors. , 2016, Journal of molecular graphics & modelling.
[93] Jon R. Wilson,et al. A key to unlocking chromatin revealed by complex structures , 2019, Nature.
[94] G. Klebe. Applying thermodynamic profiling in lead finding and optimization , 2015, Nature Reviews Drug Discovery.
[95] Maria Sjöberg,et al. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. , 2005, Molecular endocrinology.
[96] Tomás Martínek,et al. HotSpot Wizard 3.0: web server for automated design of mutations and smart libraries based on sequence input information , 2018, Nucleic Acids Res..
[97] Yong Eun Kim,et al. A Structure‐Based Virtual Screening Approach toward the Discovery of Histone Deacetylase Inhibitors: Identification of Promising Zinc‐Chelating Groups , 2010, ChemMedChem.
[98] Yuri Pevzner,et al. Fragment-Based Docking: Development of the CHARMMing Web User Interface as a Platform for Computer-Aided Drug Design , 2014, J. Chem. Inf. Model..
[99] S. Yao,et al. Unique electrocatalytic activity of a nucleic acid-mimicking coordination polymer for the sensitive detection of coenzyme A and histone acetyltransferase activity. , 2015, Chemical communications.
[100] M. Fraga,et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.
[101] G. Kleywegt,et al. Interactive motif and fold recognition in protein structures , 2002 .
[102] Siddhartha Roy,et al. Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex , 2017, The Journal of Biological Chemistry.
[103] S. Cowley,et al. Co-repressor, co-activator and general transcription factor: the many faces of the Sin3 histone deacetylase (HDAC) complex , 2018, Biochemical Journal.
[104] Ming-Lang Zhao,et al. In silico structure prediction and inhibition mechanism studies of AtHDA14 as revealed by homology modeling, docking, molecular dynamics simulation , 2018, Comput. Biol. Chem..
[105] Peter A. Jones,et al. Epigenetic Modifications as Therapeutic Targets , 2010, Nature Biotechnology.
[106] Gerrit Groenhof,et al. GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..
[107] Hualiang Jiang,et al. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening. , 2014, Journal of medicinal chemistry.
[108] Zhiping Hu,et al. The tale of histone modifications and its role in multiple sclerosis , 2018, Human Genomics.
[109] Thomas G. Gilgenast,et al. Chromatin Structure Dynamics During the Mitosis to G1-Phase Transition , 2019, Nature.
[110] D. Durocher,et al. The structural basis of modified nucleosome recognition by 53BP1 , 2016, Nature.
[111] E. Freire,et al. Binding thermodynamics of statins to HMG-CoA reductase. , 2005, Biochemistry.
[112] T. Straatsma,et al. THE MISSING TERM IN EFFECTIVE PAIR POTENTIALS , 1987 .
[113] G. Musco,et al. The biophysical and biochemical properties of the autoimmune regulator (AIRE) protein. , 2014, Biochimica et biophysica acta.
[114] D. Patel,et al. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. , 2011, Molecular cell.
[115] R. Riek,et al. Structure and dynamics conspire in the evolution of affinity between intrinsically disordered proteins , 2018, Science Advances.
[116] William J. Allen,et al. DOCK 6: Impact of new features and current docking performance , 2015, J. Comput. Chem..
[117] U. H. Danielson,et al. Biophysics in drug discovery: impact, challenges and opportunities , 2016, Nature Reviews Drug Discovery.
[118] Alessio Ciulli,et al. NMR approaches in structure-based lead discovery: Recent developments and new frontiers for targeting multi-protein complexes , 2014, Progress in biophysics and molecular biology.
[119] Chao Xu,et al. Chemical basis for the recognition of trimethyllysine by epigenetic reader proteins , 2015, Nature Communications.
[120] S. Nair,et al. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor. , 2007, Cancer research.
[121] Yun-Xing Wang,et al. Conformational dynamics of the TTD–PHD histone reader module of the UHRF1 epigenetic regulator reveals multiple histone-binding states, allosteric regulation, and druggability , 2017, The Journal of Biological Chemistry.
[122] Hidetoshi Kono,et al. H3 Histone Tail Conformation within the Nucleosome and the Impact of K14 Acetylation Studied Using Enhanced Sampling Simulation , 2016, PLoS Comput. Biol..
[123] Pierre Tufféry,et al. PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex , 2016, Nucleic Acids Res..
[124] Adrian Bird,et al. Perceptions of epigenetics , 2007, Nature.
[125] The UniProt Consortium,et al. UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..
[126] S. Berger,et al. ALCOHOL METABOLISM CONTRIBUTES TO BRAIN HISTONE ACETYLATION , 2019, Nature.
[127] F. Liu,et al. Selective histone deacetylase small molecule inhibitors: recent progress and perspectives , 2017, Expert opinion on therapeutic patents.
[128] T. Owa,et al. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study. , 2018, The Lancet. Oncology.
[129] U. Ryde,et al. Ligand-Binding Affinity Estimates Supported by Quantum-Mechanical Methods. , 2016, Chemical reviews.
[130] L. Kay,et al. Folding of an intrinsically disordered protein by phosphorylation as a regulatory switch , 2014, Nature.
[131] Qingchuan Zheng,et al. Insights into the effects of mutations on Cren7-DNA binding using molecular dynamics simulations and free energy calculations. , 2015, Physical chemistry chemical physics : PCCP.
[132] L. J. Maher,et al. Reflections on apparent DNA bending by charge variants of bZIP proteins. , 2003, Biopolymers.
[133] E. Freire,et al. Adaptive inhibitors of the HIV-1 protease. , 2005, Progress in biophysics and molecular biology.
[134] Anna R. Panchenko,et al. MutaBind estimates and interprets the effects of sequence variants on protein–protein interactions , 2016, Nucleic Acids Res..
[135] P. Kumaradhas,et al. Investigation of activation mechanism and conformational stability of N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxybenzamide and N-(4-chloro-3-trifluoromethyl-phenyl)-2-ethoxy-6-pentadecyl-benzamide in the: active site of p300 histone acetyl transferase enzyme by molecular dynamics and binding free , 2019, Journal of biomolecular structure & dynamics.
[136] Greg L. Hura,et al. Development of an improved four-site water model for biomolecular simulations: TIP4P-Ew. , 2004, The Journal of chemical physics.
[137] R. Peddinti,et al. A. baumannii histone acetyl transferase Hpa2: optimization of homology modeling, analysis of protein–protein interaction and virtual screening , 2017, Journal of biomolecular structure & dynamics.
[138] C. Allis,et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.
[139] H. Cheng,et al. The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations. , 2001, Journal of pharmacological and toxicological methods.
[140] Sylvia E. Le Dévédec,et al. Uncovering the signaling landscape controlling breast cancer cell migration identifies splicing factor PRPF4B as a metastasis driver , 2018, bioRxiv.
[141] István Horváth,et al. Exploration of Interfacial Hydration Networks of Target-Ligand Complexes , 2016, J. Chem. Inf. Model..
[142] C. Coarfa,et al. MRG15 is required for pre-mRNA splicing and spermatogenesis , 2016, Proceedings of the National Academy of Sciences.
[143] S. Knapp,et al. Targeting bromodomains: epigenetic readers of lysine acetylation , 2014, Nature Reviews Drug Discovery.
[144] J. Bray,et al. Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family , 2011, The Journal of Biological Chemistry.
[145] A. Klug,et al. Structure of the nucleosome core particle at 7 Å resolution , 1984, Nature.
[146] Luca Pinzi,et al. Molecular Docking: Shifting Paradigms in Drug Discovery , 2019, International journal of molecular sciences.
[147] I. Horváth,et al. A Fragmenting Protocol with Explicit Hydration for Calculation of Binding Enthalpies of Target-Ligand Complexes at a Quantum Mechanical Level , 2019, International journal of molecular sciences.
[148] L. Godderis,et al. Epigenetic and miRNA expression changes in people with pain: a systematic review. , 2019, The journal of pain : official journal of the American Pain Society.
[149] W. Sippl,et al. Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[150] L. Pasqualucci,et al. Emerging epigenetic-modulating therapies in lymphoma , 2019, Nature Reviews Clinical Oncology.
[151] Amedeo Caflisch,et al. Structured Water Molecules in the Binding Site of Bromodomains Can Be Displaced by Cosolvent , 2014, ChemMedChem.
[152] P. Kollman,et al. Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.
[153] D. Ferguson,et al. Drug Addiction and Histone Code Alterations. , 2017, Advances in experimental medicine and biology.
[154] Usman Tambunan,et al. Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis , 2010, BMC Bioinformatics.
[155] D. Patel,et al. Histone H3 recognition and presentation by the WDR5 module of the MLL1 complex , 2006, Nature Structural &Molecular Biology.
[156] C. Allis,et al. Translating the Histone Code , 2001, Science.
[157] T. Ran,et al. Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation. , 2015, Molecular bioSystems.
[158] K. Wellen,et al. Histone lactylation links metabolism and gene regulation , 2019, Nature.
[159] Niel M. Henriksen,et al. Attach-Pull-Release Calculations of Ligand Binding and Conformational Changes on the First BRD4 Bromodomain , 2017, Journal of chemical theory and computation.
[160] Teresa Carlomagno,et al. RNA structure determination by solid-state NMR spectroscopy , 2015, Nature Communications.
[161] Song Tan,et al. Multivalent Interactions by the Set8 Histone Methyltransferase With Its Nucleosome Substrate. , 2016, Journal of molecular biology.
[162] L. Chow,et al. Vorinostat, a pan-HDAC inhibitor, abrogates productive HPV-18 DNA amplification , 2018, Proceedings of the National Academy of Sciences.
[163] A. Ciulli,et al. Structural basis of molecular recognition of helical histone H3 tail by PHD finger domains , 2017, The Biochemical journal.
[164] C. Musselman,et al. Reading More than Histones: The Prevalence of Nucleic Acid Binding among Reader Domains , 2018, Molecules.
[165] C. Oostenbrink,et al. Advances in the calculation of binding free energies. , 2020, Current opinion in structural biology.
[166] Thomas A. Milne,et al. WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development , 2005, Cell.
[167] S. Hannenhalli,et al. Regulating the regulators: modulators of transcription factor activity. , 2010, Methods in molecular biology.
[168] Eric J. Nestler,et al. Epigenetic regulation in psychiatric disorders , 2007, Nature Reviews Neuroscience.
[169] S. Hill,et al. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2 , 2018, International journal of molecular sciences.
[170] P. Aloy,et al. Interactome3D: adding structural details to protein networks , 2013, Nature Methods.
[171] Gabriel Cornilescu,et al. Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3* , 2016, The Journal of Biological Chemistry.
[172] Sanjeev Kumar Singh,et al. Exploration of cell cycle regulation and modulation of the DNA methylation mechanism of pelargonidin: Insights from the molecular modeling approach , 2017, Comput. Biol. Chem..
[173] T. Richmond,et al. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. , 2002, Journal of molecular biology.
[174] D. Tegunov,et al. Structure of SWI/SNF chromatin remodeler RSC bound to a nucleosome , 2019, Nature.
[175] J. Li,et al. Structural insight into autoinhibition and histone H3-induced activation of DNMT3A , 2014, Nature.
[176] R. Copeland. The drug–target residence time model: a 10-year retrospective , 2015, Nature Reviews Drug Discovery.
[177] Andrew T. Fenley,et al. Modulation of nucleosomal DNA accessibility via charge-altering post-translational modifications in histone core , 2018, Epigenetics & Chromatin.
[178] E. Nestler,et al. Targeted Epigenetic Remodeling of the Cdk5 Gene in Nucleus Accumbens Regulates Cocaine- and Stress-Evoked Behavior , 2016, The Journal of Neuroscience.
[179] V. Felipo,et al. Repeated alcohol administration during adolescence causes changes in the mesolimbic dopaminergic and glutamatergic systems and promotes alcohol intake in the adult rat , 2009, Journal of neurochemistry.
[180] Hao Tang,et al. Novel Inhibitors of Human Histone Deacetylase (HDAC) Identified by QSAR Modeling of Known Inhibitors, Virtual Screening, and Experimental Validation , 2009, J. Chem. Inf. Model..
[181] Lin-Li Li,et al. Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis , 2017, J. Chem. Inf. Model..
[182] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[183] Philip C Biggin,et al. Statistical Analysis on the Performance of Molecular Mechanics Poisson–Boltzmann Surface Area versus Absolute Binding Free Energy Calculations: Bromodomains as a Case Study , 2017, J. Chem. Inf. Model..
[184] J. Widom,et al. Nucleosomes facilitate their own invasion , 2004, Nature Structural &Molecular Biology.
[185] Tania Pencheva,et al. AMMOS2: a web server for protein–ligand–water complexes refinement via molecular mechanics , 2017, Nucleic Acids Res..
[186] Clara van Emmerik,et al. Unspinning chromatin: Revealing the dynamic nucleosome landscape by NMR. , 2019, Progress in nuclear magnetic resonance spectroscopy.
[187] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[188] Robert A Copeland,et al. A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models. , 2015, Nature chemical biology.
[189] K. Houben,et al. Site‐Specific Studies of Nucleosome Interactions by Solid‐State NMR Spectroscopy , 2018, Angewandte Chemie.
[190] Junwei Shi,et al. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. , 2014, Molecular cell.
[191] Mateusz Kurcinski,et al. CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site , 2015, Nucleic Acids Res..
[192] Cen Gao,et al. Assessment of free energy predictors for ligand binding to a methyllysine histone code reader , 2012, J. Comput. Chem..
[193] I. Sagami,et al. Thermodynamic Characterization of the Ca2+-Dependent Interaction Between SOUL and ALG-2 , 2018, International journal of molecular sciences.
[194] B. Franklin Pugh,et al. Understanding nucleosome dynamics and their links to gene expression and DNA replication , 2017, Nature Reviews Molecular Cell Biology.
[195] S. Weber,et al. Methods of Measuring Enzyme Activity Ex Vivo and In Vivo. , 2018, Annual review of analytical chemistry.
[196] Andrew J. Bannister,et al. Regulation of chromatin by histone modifications , 2011, Cell Research.
[197] M. Rosales-Hernández,et al. Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations , 2017, Journal of biomolecular structure & dynamics.
[198] Cheng Luo,et al. Computer-Aided Drug Design in Epigenetics , 2018, Front. Chem..
[199] D. Hodgkin,et al. Structure of Vitamin B12: X-ray Crystallographic Evidence on the Structure of Vitamin B12 , 1954, Nature.
[200] Bing Li,et al. Readers of histone modifications , 2011, Cell Research.
[201] P. Greengard,et al. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 , 2001, Nature.
[202] K. Tobinai,et al. Targeting EZH2 with tazemetostat. , 2018, The Lancet. Oncology.
[203] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[204] A. Sali,et al. Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.
[205] C. Elmets,et al. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. , 2018, The Lancet. Oncology.
[206] Carlo Camilloni,et al. A conformational ensemble derived using NMR methyl chemical shifts reveals a mechanical clamping transition that gates the binding of the HU protein to DNA. , 2014, Journal of the American Chemical Society.
[207] J. Irudayaraj,et al. Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer , 2019, Clinical Epigenetics.
[208] J. Dubochet,et al. Cryo-electron microscopy of viruses , 1984, Nature.
[209] S. Genheden,et al. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities , 2015, Expert opinion on drug discovery.
[210] Andrew P. Feinberg,et al. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression , 2016, Nature Reviews Genetics.
[211] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[212] F. Meyer‐Almes,et al. Impact of binding mechanism on selective inhibition of histone deacetylase isoforms , 2017, Chemical biology & drug design.
[213] Aidan Budd,et al. Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation. , 2014, Chemical reviews.
[214] P. Peterson,et al. The solution structure of the first PHD finger of autoimmune regulator in complex with non-modified histone H3 tail reveals the antagonistic role of H3R2 methylation , 2009, Nucleic acids research.
[215] E. Freire. Do enthalpy and entropy distinguish first in class from best in class? , 2008, Drug discovery today.
[216] Ae Nim Pae,et al. In silico probing and biological evaluation of SETDB1/ESET-targeted novel compounds that reduce tri-methylated histone H3K9 (H3K9me3) level , 2017, Journal of Computer-Aided Molecular Design.
[217] I. Horváth,et al. Towards Unraveling the Histone Code by Fragment Blind Docking , 2019, International journal of molecular sciences.
[218] Boo Shan Tseng,et al. Dynamic Regulation of Effector Protein Binding to Histone Modifications: The Biology of HP1 Switching , 2006, Cell cycle.
[219] Vladimir B. Sulimov,et al. Semiempirical calculations of binding enthalpy for protein-ligand complexes , 2004 .
[220] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[221] T. Richmond,et al. The structure of DNA in the nucleosome core , 2003, Nature.
[222] Yan Wang,et al. SIRT2: Controversy and multiple roles in disease and physiology , 2019, Ageing Research Reviews.
[223] C. Allis,et al. Histone and chromatin cross-talk. , 2003, Current opinion in cell biology.
[224] Y. Choi,et al. The Transcriptional Corepressor, PELP1, Recruits HDAC2 and Masks Histones Using Two Separate Domains* , 2004, Journal of Biological Chemistry.
[225] Marc Vidal,et al. Ten years of genetics and genomics: what have we achieved and where are we heading? , 2010, Nature Reviews Genetics.
[226] A Comparative Molecular Dynamics Study of Methylation State Specificity of JMJD2A , 2011, PloS one.
[227] C. Roberts,et al. Targeting EZH2 in cancer , 2016, Nature Medicine.
[228] J. Davie,et al. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[229] C. Morrison,et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B , 2007, Proceedings of the National Academy of Sciences.
[230] Zhongjun Zhou,et al. Send Orders of Reprints at Reprints@benthamscience.org Chromatin Remodeling, Dna Damage Repair and Aging 2.1. Histone Modifying Enzymes , 2022 .
[231] R. Lavery,et al. Structure and Dynamics of a 197 bp Nucleosome in Complex with Linker Histone H1. , 2017, Molecular cell.
[232] Bernhard Y. Renard,et al. Docking small peptides remains a great challenge: an assessment using AutoDock Vina , 2015, Briefings Bioinform..
[233] I. Ábrahám,et al. Estradiol-Induced Epigenetically Mediated Mechanisms and Regulation of Gene Expression , 2020, International journal of molecular sciences.
[234] O. Witt,et al. HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells , 2008, Anti-cancer drugs.
[235] Ruth Nussinov,et al. PatchDock and SymmDock: servers for rigid and symmetric docking , 2005, Nucleic Acids Res..
[236] Thomas Simonson,et al. Protein side chain conformation predictions with an MMGBSA energy function , 2016, Proteins.
[237] K. Yelekçi,et al. Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors , 2019, Journal of biomolecular structure & dynamics.
[238] Hasup Lee,et al. GalaxyPepDock: a protein–peptide docking tool based on interaction similarity and energy optimization , 2015, Nucleic Acids Res..
[239] Melissa J. Davis,et al. Predicting expression: the complementary power of histone modification and transcription factor binding data , 2014, Epigenetics & Chromatin.
[240] I. Ioshikhes,et al. Structural dynamics of nucleosome mediated by acetylations at H3K56 and H3K115,122 , 2016, European Biophysics Journal.
[241] Peter A DiMaggio,et al. Histone H3 lysine 56 methylation regulates DNA replication through its interaction with PCNA. , 2012, Molecular cell.
[242] J. Irudayaraj,et al. Real-time dynamics of methyl-CpG-binding domain protein 3 and its role in DNA demethylation by fluorescence correlation spectroscopy , 2013, Epigenetics.
[243] Björn Windshügel,et al. LEADS-PEP: A Benchmark Data Set for Assessment of Peptide Docking Performance , 2016, J. Chem. Inf. Model..
[244] Petr Klus,et al. catRAPID omics: a web server for large-scale prediction of protein–RNA interactions , 2013, Bioinform..
[245] M. Carroll,et al. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies , 2014, Leukemia.
[246] Jian-hui Jiang,et al. Surface enhanced Raman scattering based sensitive detection of histone demethylase activity using a formaldehyde-selective reactive probe. , 2013, Chemical communications.
[247] Min Gyu Lee,et al. Structural insights into trans-histone regulation of H3K4 methylation by unique histone H4 binding of MLL3/4 , 2019, Nature Communications.
[248] T. Eckschlager,et al. KDM5 demethylases and their role in cancer cell chemoresistance , 2018, International journal of cancer.
[249] Andrea Baccarelli,et al. Epigenetics and lifestyle. , 2011, Epigenomics.
[250] Y. Dou,et al. Cryo-EM structure of the human MLL1 core complex bound to the nucleosome , 2019, Nature Communications.
[251] David van der Spoel,et al. Systematic exploration of multiple drug binding sites , 2017, Journal of Cheminformatics.
[252] Raju Dash,et al. Structural dynamics and quantum mechanical aspects of shikonin derivatives as CREBBP bromodomain inhibitors. , 2018, Journal of molecular graphics & modelling.
[253] Junhong Han,et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials , 2019, Signal Transduction and Targeted Therapy.
[254] Rika Takikawa,et al. [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[255] Yu Cao,et al. Virtual screening in small molecule discovery for epigenetic targets. , 2015, Methods.
[256] D. Lipman,et al. Rapid and sensitive protein similarity searches. , 1985, Science.
[257] Weidong Zhu,et al. Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels , 2019, International journal of molecular sciences.
[258] Ronen Zangi,et al. Molecular Dynamics Study of the Recognition of Dimethylated CpG Sites by MBD1 Protein , 2015, J. Chem. Inf. Model..
[259] S. Singh,et al. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain , 2018, Journal of biomolecular structure & dynamics.
[260] E. di Luccio. Journal of Cancer Prevention Inhibition of Nuclear Receptor Binding Set Domain 2/ Multiple Myeloma Set Domain by Lem-06 Implication for Epigenetic Cancer Therapies , 2022 .
[261] C. Allis,et al. The language of covalent histone modifications , 2000, Nature.
[262] C. Allis,et al. Chromatin remodeling and cancer, Part I: Covalent histone modifications. , 2007, Trends in molecular medicine.
[263] F. H. Garrison. The history of cancer. , 2012, Bulletin of the New York Academy of Medicine.
[264] P. O'Brien,et al. Transient Kinetic Methods for Mechanistic Characterization of DNA Binding and Nucleotide Flipping. , 2017, Methods in enzymology.
[265] Dan Li,et al. HawkDock: a web server to predict and analyze the protein–protein complex based on computational docking and MM/GBSA , 2019, Nucleic Acids Res..
[266] B. Kaang,et al. Epigenetic regulation and chromatin remodeling in learning and memory , 2017, Experimental & Molecular Medicine.